Tag:
TOK-001
Latest Headlines
Latest Headlines
Tokai unveils promising Phase I data for 'triple whammy' prostate cancer contender
Cambridge, MA-based Tokai Pharmaceuticals presented a promising set of Phase I data pointing to the early efficacy of its "triple whammy" pill for castration-resistant prostate cancer.
Tokai lands new CEO, $23M venture round for PhIIb cancer study
Cambridge, MA-based Tokai Pharmaceuticals has rounded up a $23 million venture round to push its lead treatment for prostate cancer into mid-stage trials. And its board has tapped an experienced
Tokai Pharmaceuticals lands $12M in funding
Cambridge, MA-based Tokai Pharmaceuticals has rounded up $12 million in funding as part of a $22 million equity-financing round. Apple Tree Partners, which founded the company, contributed the money.
